AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer therapy, in part because they interrupt cell cycle progression in transformed cell lines. To examine cell cycle arrest induced by HDAC inhibitor trichostatin A (TSA), a cytoblot cell-based screen was used to identify small molecule suppressors of this process. TSA suppressors (ITSAs) counteract TSA-induced cell cycle arrest, histone acetylation, and transcriptional activation. Hydroxamic acid-based HDAC inhibitors like TSA and suberoylanilide hydroxamic acid (SAHA) promote acetylation of cytoplasmic α-tubulin as well as histones, a modification also suppressed by ITSAs. Although tubulin acetylation appears irrelevant to cell cycle progression ...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
Histone deacetylase (HDAC) inhibitors have been shown to be potent inducers of growth arrest, differ...
In cells with an altered p53 gene, the expression of p21WAF1/CIP1, a potent inhibitor of cyclin-depe...
AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer t...
Background Histone deacetylase (HDAC) inhibitors are a group of small chemical molecules that inhibi...
Inhibitors of histone deacetylases (HDAC) are an important emerging class of drugs for the treatment...
AbstractHistone deacetylase (HDAC) inhibitors arrest human tumor cells at the G1 phase of the cell c...
Inhibitors of histone deacetylases (HDAC) are an important emerging class of drugs for the treatment...
Research performed over the last decade has highlighted the role of HDAC inhibitors (HDACis) as modu...
Epigenetic alterations of the histone acetylation play an important role in the regulation of gene e...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
We have previously used the ATAD5-luciferase high-throughput screening assay to identify genotoxic c...
We have previously used the ATAD5-luciferase high-throughput screening assay to identify genotoxic c...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
Histone deacetylase (HDAC) inhibitors have been shown to be potent inducers of growth arrest, differ...
In cells with an altered p53 gene, the expression of p21WAF1/CIP1, a potent inhibitor of cyclin-depe...
AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer t...
Background Histone deacetylase (HDAC) inhibitors are a group of small chemical molecules that inhibi...
Inhibitors of histone deacetylases (HDAC) are an important emerging class of drugs for the treatment...
AbstractHistone deacetylase (HDAC) inhibitors arrest human tumor cells at the G1 phase of the cell c...
Inhibitors of histone deacetylases (HDAC) are an important emerging class of drugs for the treatment...
Research performed over the last decade has highlighted the role of HDAC inhibitors (HDACis) as modu...
Epigenetic alterations of the histone acetylation play an important role in the regulation of gene e...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
We have previously used the ATAD5-luciferase high-throughput screening assay to identify genotoxic c...
We have previously used the ATAD5-luciferase high-throughput screening assay to identify genotoxic c...
Uncontrolled cell proliferation and resistance to apoptosis in cancer are, among others, regulated b...
Histone deacetylase (HDAC) inhibitors have been shown to be potent inducers of growth arrest, differ...
In cells with an altered p53 gene, the expression of p21WAF1/CIP1, a potent inhibitor of cyclin-depe...